They should not be used by: People with a history of pancreatitis (inflammation of the pancreas) Anyone with a personal or family history of medullary thyroid cancer (a rare type of thyroid cancer) People with multiple endocrine neoplasia type 2 (MEN 2, a rare inherited condition that raises the risk of certain hormone-related tumors, including thyroid cancer) Women who are pregnant or breastfeeding People with severe stomach or bowel problems, such as gastroparesis (slow stomach emptying that causes nausea, fullness, or vomiting) or inflammatory bowel disease (chronic inflammation of the digestive tract, such as Crohns disease or ulcerative colitis) Those with severe kidney problems, especially with certain types of GLP-1 medicines, such as exenatide Anyone with allergies to GLP-1 medications or who has had a severe reaction to them Use in children is limited to certain GLP-1 medicines approved for adolescents with obesity
This dual-action approach provides a comprehensive solution for individuals managing the combined challenges of type 2 diabetes and obesity, positioning Liraglutide as an innovative and versatile option for overall metabolic health and weight management
For example, the elevated IOP in glaucoma eyes exerts mechanical stress at the optic nerve head, a key site for RGC damage, and leads to neurodegeneration and visual impairment
Before starting treatment, verify that your provider uses LegitScript-certified pharmacies and ask whether the compounded medication undergoes third-party potency and sterility testing
